Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Agency for Healthcare Research and Quality (AHRQ) | FED |
The purpose of this research is to improve our understanding of the effects that taking cholesterol reducing pills have on dietary behavior as well as other health related behaviors
This study explores the impact of initiating statin therapy on subsequent dietary as well as other lifestyle beliefs, attitudes and behaviors.
Specific aims:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Drug and Dietary behavior | Behavioral |
| Measure | Description | Time Frame |
|---|---|---|
| How drug or dietary therapy may play a role in dietary behavior. |
Not provided
Not provided
Inclusion Criteria:
All English-speaking adults who have recently (within 1 week)received their first prescription for a statin will be eligible.
Exclusion Criteria:
Will include a history of any of the following:
Not provided
Not provided
Not provided
All English-speaking adults who have recently (within 1 week)received their first prescription for a statin will be eligible.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sundar Natarajan, MD, MSc | Weill Medical College of Cornell University | Principal Investigator |
| Devin Mann, MD | Weill Medical College of Cornell University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The New York Presbyterian Hospital-Weill Medical Center | New York | New York | 10021 | United States |
Not provided
| ID | Term |
|---|---|
| D001519 | Behavior |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004364 | Pharmaceutical Preparations |
Not provided
Not provided
Not provided